Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Mehr anzeigen
Achieved $11 million in ZURZUVAE® (zuranolone) collaboration revenue during the third quarter of 2024 (50% of the net revenue recorded by Biogen), representing 49% growth from the second...
Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE PR Newswire LOS ANGELES, Oct. 28, 2024 LOS ANGELES, Oct. 28, 2024 /PRNewswire/...
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGE PR Newswire NEW YORK, Oct. 28, 2024 NEW YORK, Oct. 28, 2024...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.32 | -21.1878009631 | 6.23 | 6.28 | 4.735 | 798616 | 5.26051427 | CS |
| 4 | -2.89 | -37.0512820513 | 7.8 | 8.7 | 4.735 | 833673 | 6.45033742 | CS |
| 12 | -3.27 | -39.9755501222 | 8.18 | 8.7 | 4.735 | 690728 | 6.97188934 | CS |
| 26 | -6.79 | -58.0341880342 | 11.7 | 13.47 | 4.735 | 906985 | 9.41001621 | CS |
| 52 | -14.35 | -74.5067497404 | 19.26 | 28.26 | 4.735 | 932988 | 14.69100089 | CS |
| 156 | -35.95 | -87.9833578071 | 40.86 | 59.99 | 4.735 | 815971 | 26.44563042 | CS |
| 260 | -141.74 | -96.6518922605 | 146.65 | 159.99 | 4.735 | 815498 | 38.73894644 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
